UK small-cap RNS · 24 Sep 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
| Date | Company | Mcap | Who | Amount | % mcap | ||
|---|---|---|---|---|---|---|---|
| 24 Sep | DSW Capital DSW | £11m | A director · Executive Director
|
Buy | £50k | 0.44% | |
| 24 Sep | Trufin TRU | £54m | James van den Bergh · Chief Executive Officer
|
Buy | – | – | |
| 24 Sep | Oxford Biomedica OXB | £622m | A director · Non-Executive Director
|
Buy | – | – | |
| 24 Sep | Origin Enterprises (CDI) OGN | £362m | Colm Purcell · Chief Financial Officer / PDMR Sean Coyle · Chief Executive Officer / PDMR John Hennessy · Non-Executive Chairman / PDMR
|
Buy | – | – | |
| 24 Sep | CVS Group CVSG | £884m | Laura Hagan · PDMR (Non-Executive Director)
|
Buy | – | – |
Purchases and sales with the directors' own money, from the forms they file (MAR article 19); awards, vesting, option exercises, share plans and sales for tax are under All. Not investment advice.